Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Reporting Tumor Genomic Test Results To Seer Registries Via Linkages

Reporting tumor genomic test results to SEER registries via linkages

Valentina I Petkov1, Jung S Byun1, Kevin C Ward2

  • 1Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Journal of the National Cancer Institute. Monographs
|August 5, 2024

Related Experiment Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239

View abstract on PubMed

Summary
This summary is machine-generated.

The National Cancer Institute

Related Experiment Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239

Area of Science:

  • Cancer surveillance
  • Genomic data integration
  • Population health research

Background:

  • Precision medicine is crucial in cancer care.
  • The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program lacks comprehensive tumor genomic data.
  • This data gap hinders population-based research on molecular subtypes.

Purpose of the Study:

  • To establish a centralized process for linking SEER cancer cases with molecular test results.
  • To enhance cancer surveillance data with crucial genomic information.
  • To facilitate population-based research on cancer molecular subtypes.

Main Methods:

  • Utilized established operating procedures for centralized data linkages.
  • Employed Match*Pro probabilistic linkage software.
  • Leveraged a trusted third-party honest broker for facilitation.

Main Results:

  • Successfully linked SEER tumor cases with various genomic test results.
  • Included OncotypeDX Breast Recurrence Score, OncotypeDX Breast Ductal Carcinoma in Situ, OncotypeDX Genomic Prostate Score, Decipher Prostate Genomic Classifier, and DecisionDX melanoma tests.
  • Incorporated germline test results from Georgia and California SEER registries.

Conclusions:

  • Linking SEER cancer cases with genomic test results is an effective data collection strategy for cancer surveillance.
  • The National Cancer Institute's SEER Program provides de-identified data for extensive research.
  • Enables scientists to address diverse research questions in cancer genomics and epidemiology.